paraoxon has been researched along with Absence Status in 10 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (10.00) | 29.6817 |
2010's | 7 (70.00) | 24.3611 |
2020's | 2 (20.00) | 2.80 |
Authors | Studies |
---|---|
Bar-Klein, G; Eisenkraft, A; Friedman, A; Kamintsky, L; Prager, O; Rosman, Y; Serlin, Y; Shrot, S; Statlender, L; Swissa, E; Weissberg, I | 1 |
Blair, RE; DeLorenzo, RJ; Deshpande, LS; Halquist, M; Kosmider, L | 1 |
Chapman, J; Eisenkraft, A; Gera, O; Golderman, V; Maggio, N; Shavit-Stein, E | 1 |
Bar-Klein, G; Chai, O; Elkin, M; Friedman, A; Hanael, E; Kaufer, D; Konstantin, L; Peery, D; Senatorov, VV; Shamir, MH; Veksler, R | 1 |
Blair, RE; Carter, DS; DeLorenzo, RJ; Deshpande, LS; Phillips, KF | 1 |
Bar-Klein, G; Biala, Y; Daninos, M; Friedman, A; Kamintsky, L; Kassirer, M; Krivoy, A; Lavon, O; Makarovsky, I; Ramaty, E; Rosman, Y; Shrot, S; Statlender, L; Yaari, Y | 1 |
Bar-Klein, G; Bialer, M; Eisenkraft, A; Friedman, A; Hubary, Y; Kamintsky, L; Saar-Ashkenazy, R; Shekh-Ahmad, T; Shrot, S; Stetlander, L; Swissa, E | 1 |
Apland, JP; Aroniadou-Anderjaska, V; Braga, MF; Figueiredo, TH; Krishnan, JK; Miller, SL; Pidoplichko, VI | 1 |
Balint, CA; Cowan, ML; Kapur, J; Sun, C; Todorovic, MS | 1 |
Goodkin, HR; Joshi, S; Kapur, J; Kozhemyakin, M | 1 |
1 trial(s) available for paraoxon and Absence Status
Article | Year |
---|---|
Blood-brain barrier dysfunction in canine epileptic seizures detected by dynamic contrast-enhanced magnetic resonance imaging.
Topics: Albumins; Algorithms; Animals; Blood-Brain Barrier; Brain Neoplasms; Contrast Media; Convulsants; Dog Diseases; Dogs; Epilepsy; Gliosis; Magnetic Resonance Imaging; Neuroimaging; Paraoxon; Piriform Cortex; Prospective Studies; Rats; Serum Albumin; Signal Transduction; Status Epilepticus; Transforming Growth Factor beta | 2019 |
9 other study(ies) available for paraoxon and Absence Status
Article | Year |
---|---|
Midazolam and isoflurane combination reduces late brain damage in the paraoxon-induced status epilepticus rat model.
Topics: Animals; Anticonvulsants; Brain; Disease Models, Animal; Isoflurane; Male; Midazolam; Paraoxon; Rats, Sprague-Dawley; Status Epilepticus | 2020 |
Intramuscular atenolol and levetiracetam reduce mortality in a rat model of paraoxon-induced status epilepticus.
Topics: Administration, Oral; Animals; Atenolol; Injections, Intramuscular; Levetiracetam; Male; Paraoxon; Rats; Rats, Sprague-Dawley; Status Epilepticus | 2020 |
Thrombin and the Protease-Activated Receptor-1 in Organophosphate-Induced Status Epilepticus.
Topics: Animals; Cholinesterase Inhibitors; Hippocampus; Male; Mice; Mice, Inbred C57BL; Mitogen-Activated Protein Kinase 1; Paraoxon; Prothrombin; Receptors, Thrombin; Status Epilepticus | 2019 |
Development of status epilepticus, sustained calcium elevations and neuronal injury in a rat survival model of lethal paraoxon intoxication.
Topics: Animals; Anticonvulsants; Atropine; Brain; Calcium; Diazepam; Disease Models, Animal; Electroencephalography; Hippocampus; Male; Neurons; Organophosphate Poisoning; Paraoxon; Pralidoxime Compounds; Rats; Rats, Sprague-Dawley; Status Epilepticus | 2014 |
Prevention of organophosphate-induced chronic epilepsy by early benzodiazepine treatment.
Topics: Animals; Antidotes; Atropine; Cholinesterase Inhibitors; Cholinesterase Reactivators; Chronic Disease; Epilepsy; Midazolam; Muscarinic Agonists; Obidoxime Chloride; Paraoxon; Pesticides; Pilocarpine; Rats; Rats, Sprague-Dawley; Status Epilepticus | 2014 |
sec-Butyl-propylacetamide (SPD) and two of its stereoisomers rapidly terminate paraoxon-induced status epilepticus in rats.
Topics: Amides; Animals; Anticonvulsants; Disease Models, Animal; Electroencephalography; Insecticides; Male; Paraoxon; Rats; Rats, Sprague-Dawley; Statistics, Nonparametric; Status Epilepticus; Stereoisomerism; Treatment Outcome; Valproic Acid | 2014 |
The M1 Muscarinic Receptor Antagonist VU0255035 Delays the Development of Status Epilepticus after Organophosphate Exposure and Prevents Hyperexcitability in the Basolateral Amygdala.
Topics: Animals; Basolateral Nuclear Complex; Male; Paraoxon; Rats; Rats, Sprague-Dawley; Receptor, Muscarinic M1; Soman; Status Epilepticus; Sulfonamides; Synapses; Thiadiazoles | 2017 |
Characterization of status epilepticus induced by two organophosphates in rats.
Topics: Animals; Anticonvulsants; Atropine; Brain; Diazepam; Electroencephalography; Isoflurophate; Male; Neurons; Paraoxon; Rats; Rats, Sprague-Dawley; Seizures; Status Epilepticus | 2012 |
Impact of receptor changes on treatment of status epilepticus.
Topics: Action Potentials; Animals; Benzodiazepines; Cholinesterase Inhibitors; Disease Models, Animal; Drug Resistance; Excitatory Postsynaptic Potentials; gamma-Aminobutyric Acid; Humans; Male; Paraoxon; Patch-Clamp Techniques; Rats; Rats, Sprague-Dawley; Receptors, GABA-A; Seizures; Status Epilepticus; Synaptic Transmission | 2007 |